Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nukkleus (NUKK) EBIT (2022 - 2025)

Historic EBIT for Nukkleus (NUKK) over the last 4 years, with Q2 2025 value amounting to -$1.0 million.

  • Nukkleus' EBIT fell 183.87% to -$1.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$4.8 million, marking a year-over-year increase of 8189.77%. This contributed to the annual value of -$14.2 million for FY2024, which is 1881.22% up from last year.
  • According to the latest figures from Q2 2025, Nukkleus' EBIT is -$1.0 million, which was down 183.87% from -$1.5 million recorded in Q1 2025.
  • In the past 5 years, Nukkleus' EBIT ranged from a high of -$806364.0 in Q1 2023 and a low of -$14.3 million during Q3 2023
  • For the 4-year period, Nukkleus' EBIT averaged around -$3.3 million, with its median value being -$1.2 million (2023).
  • Its EBIT has fluctuated over the past 5 years, first crashed by 68726.51% in 2023, then skyrocketed by 9169.19% in 2024.
  • Over the past 4 years, Nukkleus' EBIT (Quarter) stood at -$1.1 million in 2022, then tumbled by 687.27% to -$8.9 million in 2023, then skyrocketed by 86.71% to -$1.2 million in 2024, then rose by 11.81% to -$1.0 million in 2025.
  • Its last three reported values are -$1.0 million in Q2 2025, -$1.5 million for Q1 2025, and -$1.2 million during Q3 2024.